InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（7 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Tari Leslie, Directeur Scientifique. Officer active across 1 company, notably Cidara Therapeutics, Inc.. Aggregated, 13 disclosures have been recorded. Breakdown: 1 buy · 7 sells. Total volume traded: €120k. Activity tracked since 30 September 2021. The latest transaction was filed on 11 March 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Tari Leslie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
1,773 股@ US$21.962630.0% 占其流量Common StockSEC:0001610618-25-000023:0
909 股@ US$11.63938.0% 占其流量Common StockSEC:0001610618-24-000123:0
111,250 股0Common StockSEC:0001610618-24-000025:0
21,029 股@ US$0.669810.7% 占其流量Common StockSEC:0001610618-24-000016:0
18,469 股@ US$0.94813.6% 占其流量Common StockSEC:0001610618-23-000090:0
10,000 股@ US$0.977.4% 占其流量Common StockSEC:0001610618-23-000083:0
标准退出：2023年11月12日 (T+90)
90,000 股0Common StockSEC:0001610618-23-000030:0
7,562 股@ US$1.539.0% 占其流量Common StockSEC:0001610618-23-000012:0
11,814 股@ US$1.2011.0% 占其流量Common StockSEC:0001610618-23-000003:0
18,159 股@ US$0.684910.2% 占其流量Common StockSEC:0001610618-22-000078:0
52,500 股0Common StockSEC:0001610618-22-000021:0
2,101 股0Common StockSEC:0001209191-22-002600:0
148,000 股0Common StockSEC:0001610618-21-000089:0
13 条申报中的 13 条
About Tari Leslie
Tari Leslie is Chief Scientific Officer at Cidara Therapeutics, Inc. Across 13 total filings, the 13 sampled filings, from 2021-10-04 to 2025-03-13, show buy transactions of EUR 8891 and sell transactions of EUR 110967, with Cession as the modal transaction nature.
